Bg pattern

IBIS 20 mg ORALLY DISPERSIBLE TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use IBIS 20 mg ORALLY DISPERSIBLE TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ibis 20 mg Oral Disintegrating Tablets

bilastine

Read this package leaflet carefully before starting to take this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Ibis and what is it used for
  2. What you need to know before taking Ibis
  3. How to take Ibis
  4. Possible side effects
  5. Storage of Ibis
  6. Package Contents and Additional Information

1. What is Ibis and what is it used for

Ibis contains bilastine as the active substance, which is an antihistamine.

Ibis is used to relieve the symptoms of allergic rhinoconjunctivitis (sneezing, nasal itching, nasal discharge, nasal congestion, and red and itchy eyes) and other forms of allergic rhinitis. It may also be used to treat itchy skin eruptions (hives or urticaria).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Ibis

Do not take Ibis

If you are allergic to bilastine or any of the other ingredients of this medicine (listed in section 6).

Warnings and Precautions

Consult your doctor or pharmacist before starting to use this medicine if you have moderate or severe kidney problems, low blood potassium levels, magnesium, calcium, if you have or have had heart rhythm problems or if your heart rate is very low, if you are taking medicines that may affect your heart rhythm, if you have or have had a certain abnormal heart rhythm pattern (known as QTc interval prolongation in the electrocardiogram) that may occur in some types of heart disease and are also taking other medicines (see "Use of Ibis with other medicines").

Children

Do not give this medicine to children under 12 years of age.

Do notexceed the recommended dose. If symptoms persist, consult your doctor.

Other medicines and Ibis

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

In particular, please inform your doctor if you are taking any of the following medicines:

  • Ketoconazole (an antifungal medicine)
  • Erythromycin (an antibiotic)
  • Diltiazem (for angina pectoris - chest pain or pressure)
  • Ciclosporin (to reduce the activity of your immune system, and thus prevent transplant rejection or reduce disease activity in autoimmune and allergic disorders, such as psoriasis, atopic dermatitis, or rheumatoid arthritis)
  • Ritonavir (for AIDS)
  • Rifampicin (an antibiotic)

Taking Ibis with food, drinks, and alcohol

These oral disintegrating tablets must notbe taken with foodor withgrapefruit juice or other fruit juices, as this would decrease the effect of bilastine. To avoid this, you can:

  • take the oral disintegrating tablet and wait one hour before eating or drinking fruit juices, or

Bilastine, at the recommended dose (20 mg), does not increase the drowsiness caused by alcohol.

Pregnancy, breastfeeding, and fertility

There are no data or limited data on the use of bilastine in pregnant women, during breastfeeding, or on fertility.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Consult your doctor or pharmacist before using any medicine.

Driving and using machines

It has been shown that bilastine 20 mg does not affect performance during driving in adults. However, each patient's response to the medicine may be different. Therefore, check how this medicine affects you before driving or using machines.

Ibis contains sodium and ethanol

This medicine contains less than 1 mmol of sodium (23 mg) per oral disintegrating tablet; this is essentially "sodium-free".

This medicine contains 0.0030 mg of alcohol (ethanol) in each oral disintegrating tablet, which is equivalent to 1.6 mg/100 g (0.0016% w/w). The amount of alcohol in a 185 mg oral disintegrating tablet is equivalent to less than 1 ml of beer or 1 ml of wine.

The small amount of alcohol in this medicine does not produce any noticeable effect.

3. How to take Ibis

Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose in adults, including elderly patients and adolescents from 12 years of age, is 1 oral disintegrating tablet (20 mg of bilastine) per day.

  • The oral disintegrating tablet is for oral use.
  • Please place the oral disintegrating tablet in the mouth. It will disperse rapidly in the saliva and can then be swallowed easily.
  • Alternatively, you can disperse the oral disintegrating tablet in water before taking it.
  • You should use only water for dispersion,do not use grapefruit juice or any other fruit juice.
  • The oral disintegrating tablet should be taken one hour before or two hours after taking any food or fruit juice (see section 2, "Taking Ibis with food, drinks, and alcohol").

Regarding the duration of treatment, your doctor will determine the type of disease you have and indicate how long you should take this medicine.

Use in children

For children from 6 to 11 years of age with a minimum body weight of 20 kg, there are other pharmaceutical forms more suitable - bilastine 10 mg oral disintegrating tablets or bilastine 2.5 mg/ml oral solution -, consult your doctor or pharmacist.

Do not give bilastine to children under 6 years of age with a body weight below 20 kg as there are not enough data.

If you take more Ibis than you should

If you or anyone else takes too much of this medicine, tell your doctor immediatelyor go to the nearest hospital emergency department. Please remember to take this medicine package or this package leaflet with you.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Ibis

Do not take a double dose to make up for a forgotten dose.

If you forget to take your dose, take it as soon as possible, and then return to your normal dosing schedule.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

If you stop taking Ibis

Generally, no effects will appear after stopping this treatment.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience allergic reactions whose symptoms may include difficulty breathing, dizziness, collapse, or loss of consciousness, swelling of the face, lips, tongue, or throat, and/or swelling and redness of the skin, stop taking this medicine and seek medical attention immediately.

Other side effects that may occur in adults and adolescents are:

Common: may affect up to 1 in 10 people

  • headache
  • drowsiness

Uncommon: may affect up to 1 in 100 people

  • electrocardiogram changes
  • blood tests showing changes in liver function
  • dizziness
  • stomach pain
  • fatigue
  • increased appetite
  • irregular heartbeat
  • weight gain
  • nausea (feeling sick)
  • anxiety
  • dry or irritated nose
  • abdominal pain
  • diarrhea
  • gastritis (inflammation of the stomach lining)
  • vertigo (feeling of dizziness or instability)
  • feeling of weakness
  • thirst
  • shortness of breath
  • dry mouth
  • indigestion
  • itching
  • cold sores
  • fever
  • tinnitus (ringing in the ears)
  • difficulty sleeping
  • blood tests showing changes in kidney function
  • increased blood fats

Frequency not known: cannot be estimated from the available data

  • palpitations (feeling of heartbeats)
  • tachycardia (fast heart rate)
  • vomiting

Side effects that may occur in children:

Common: may affect up to 1 in 10 people

  • rhinitis (nasal irritation)
  • allergic conjunctivitis (eye inflammation due to an allergic reaction)
  • headache
  • stomach pain (abdominal pain/upper abdominal pain)

Uncommon: may affect up to 1 in 100 people

  • eye irritation
  • dizziness
  • loss of consciousness
  • diarrhea
  • nausea (feeling sick)
  • lip swelling
  • eczema
  • urticaria (hives)
  • fatigue

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly to the Spanish Medicines and Healthcare Products Agency (AEMPS) through the website www.notificaRAM.es

By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ibis

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging and blister after EXP. The expiry date is the last day of the month stated.

This medicine does not require any special storage conditions.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Package Contents and Additional Information

Composition of Ibis

  • The active substance is bilastine. Each oral disintegrating tablet contains 20 mg of bilastine.
  • The other ingredients are: mannitol (E421), croscarmellose sodium, sodium stearyl fumarate, sucralose (E955), red grape flavor (main components: gum arabic, ethyl butyrate, triacetin, methyl anthranilate, ethanol, d-limonene, linalool)

Appearance of the product and package contents

Ibis 20 mg oral disintegrating tablets are round, flat, white, engraved with "20" on one side, and 8 mm in diameter.

Ibis 20 mg oral disintegrating tablets are available in single-dose precut blisters of 10 x 1, 20 x 1, 30 x 1, 40 x 1, 50 x 1 oral disintegrating tablets.

Not all pack sizes may be marketed.

Marketing Authorization Holder

Menarini International Operations Luxembourg, S.A.

1, Avenue de la Gare

L-1611 Luxembourg

Local Representative:

Laboratorios Menarini, S.A.

Alfons XII, 587 – E 08918 Badalona (Barcelona)

Manufacturer

FAES FARMA, S.A.

Máximo Aguirre, 14

48940 – Leioa

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Germany: Bilaxten 20 mg Schmelztabletten

Austria: Olisir 20 mg Schmelztabletten

Belgium: Bellozal 20 mg orodispersible tablets

Bulgaria: ???????? ?? ???? 20 mg ???????????? ?? ? ?????? ????????

Cyprus: Bilaz 20 mg δισκ?α διασπειρ?μενα στο στ?μα

Croatia: Nixar 20 mg raspadljive tablete za usta

Slovenia: Bilador 20 mg orodisperzibilne tablete

Spain: Ibis 20 mg comprimidos bucodispersables

Estonia: Opexa

Finland: Revitelle 20 mg tabletti, suussa hajoava

France: Bilaska 20 mg comprimé orodispersible

Greece: Bilaz 20 mg δισκ?α διασπειρ?μενα στο στ?μα

Hungary: Lendin 20 mg szájban diszpergálódó tabletta

Italy: Bysabel 20 mg compressa orodispersibile

Ireland: Drynol 20 mg orodispersible tablets

Latvia: Opexa 20 mg mute dispergejamas tabletes

Lithuania: Opexa 20 mg burnoje disperguojamos tabletes

Luxembourg: Bellozal 20 mg orodispersible tablets

Malta: Gosall 20 mg orodispersible tablets

Poland: Clatra

Portugal: Lergonix 20 mg comprimido orodispersível

Czech Republic: Xados

Slovakia: Omarit 20 mg orodispergovatelné tablety

Romania: Borenar 20 mg comprimate orodispersabile

Date of last revision of this package leaflet:April 2025

Other sources of information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for IBIS 20 mg ORALLY DISPERSIBLE TABLETS

Discuss questions about IBIS 20 mg ORALLY DISPERSIBLE TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for IBIS 20 mg ORALLY DISPERSIBLE TABLETS?
IBIS 20 mg ORALLY DISPERSIBLE TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in IBIS 20 mg ORALLY DISPERSIBLE TABLETS?
The active ingredient in IBIS 20 mg ORALLY DISPERSIBLE TABLETS is bilastine. This information helps identify medicines with the same composition but different brand names.
How much does IBIS 20 mg ORALLY DISPERSIBLE TABLETS cost in pharmacies?
The average pharmacy price for IBIS 20 mg ORALLY DISPERSIBLE TABLETS is around 5.82 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures IBIS 20 mg ORALLY DISPERSIBLE TABLETS?
IBIS 20 mg ORALLY DISPERSIBLE TABLETS is manufactured by Menarini International Operations Luxembourg S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of IBIS 20 mg ORALLY DISPERSIBLE TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether IBIS 20 mg ORALLY DISPERSIBLE TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to IBIS 20 mg ORALLY DISPERSIBLE TABLETS?
Other medicines with the same active substance (bilastine) include ABISAX 20 mg TABLETS, ABRILIA 20 mg TABLETS, ASTRILAX 20 mg TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media